Intuitive Surgical Q4 EPS Beats by 12.4% with $2.87B Revenue
Intuitive Surgical posted Q4 adjusted EPS of $2.53, topping consensus by 12.4%, and revenue of $2.87 billion, exceeding estimates by 4.7%. The company’s 15.7% long-term earnings growth forecast outpaces the 14% industry average and follows four consecutive quarters of positive earnings surprises averaging 13.2%.
1. Q4 2025 Financial Results
Intuitive Surgical delivered adjusted EPS of $2.53 in Q4 2025, beating the consensus estimate by 12.4%, and generated $2.87 billion in revenue, surpassing forecasts by 4.7%. The top-line outperformance was driven by strong demand for its da Vinci surgical systems across key markets.
2. Growth Outlook
Management maintains a long-term earnings growth estimate of 15.7%, above the industry average of 14%, reflecting expected expansion in minimally invasive surgery adoption and recurring revenue from instruments and accessories.
3. Earnings Surprise Track Record
The company has beaten EPS consensus in each of the past four quarters, with an average surprise of 13.2%, underscoring consistent operational leverage and disciplined cost management.
4. Stock Market Implications
The robust quarterly beat and elevated growth path could support multiple expansion for Intuitive Surgical shares, with analysts likely to reassess 2026 estimates based on sustained procedure volume growth.